March 21, 2018 / 12:10 PM / 9 months ago

BRIEF-Achaogen Says FDA to Review Plazomicin By June 25

March 21 (Reuters) - Achaogen Inc:

* ACHAOGEN ANNOUNCES DATE OF FDA ADVISORY COMMITTEE MEETING FOR PLAZOMICIN

* ACHAOGEN INC - ‍TARGET ACTION DATE UNDER PRESCRIPTION DRUG USER FEE ACT (PDUFA) IS JUNE 25, 2018​

* ACHAOGEN INC - ‍FDA STATED IT WAS PLANNING TO HOLD ADVISORY COMMITTEE MEETING, CO ANNOUNCED MEETING IS PLANNED FOR MAY 2 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below